Anthrax Therapeutic Pipeline Review, H1 2015

1
Anthrax Pipeline Review, H1 2015 By RnRMarketRes
earch

• Browse more reports on Pharmaceuticals at
  http//www.rnrmarketresearch.com/reports/life-scie
  nces/pharmaceuticals

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
2
Anthrax Pipeline Review, H1 2015

• Global Markets Directs, Anthrax Pipeline
  Review, H1 2015', provides an overview of the
  Anthraxs therapeutic pipeline.
• This report provides comprehensive information on
  the therapeutic development for Anthrax, complete
  with comparative analysis at various stages,
  therapeutics assessment by drug target, mechanism
  of action (MoA), route of administration (RoA)
  and molecule type, along with latest updates, and
  featured news and press releases. It also reviews
  key players involved in the therapeutic
  development for Anthrax and special features on
  late-stage and discontinued projects.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
3
Anthrax Pipeline Review, H1 2015
The report enhances decision making capabilities
and help to create effective counter strategies
to gain competitive advantage. It strengthens RD
pipelines by identifying new targets and MOAs to
produce first-in-class and best-in-class
products.  The report is built using data and
information sourced from Global Markets Directs
proprietary databases, Company/University
websites, SEC filings, investor presentations and
featured press releases from company/university
sites and industry-specific third party sources,
put together by Global Markets Directs
team. Note Certain sections in the report may
be removed or altered based on the availability
and relevance of data for the indicated
disease. Complete Report is available at
http//www.rnrmarketresearch.com/anthrax-pipeline-
review-h1-2015-market-report.html .
http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
4
Anthrax Pipeline Review, H1 2015

• Scope
• The report summarizes all the dormant and
  discontinued pipeline projects.
• The report reviews key players involved in the
  therapeutics development for Anthrax and enlists
  all their major and minor projects.
• The report reviews key pipeline products under
  drug profile section which includes product
  description, MoA and RD brief, licensing and
  collaboration details other developmental
  activities.
• The report provides a snapshot of the global
  therapeutic landscape of Anthrax.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
5
Anthrax Pipeline Review, H1 2015

• Reasons to Buy
• Plan mergers and acquisitions effectively by
  identifying key players of the most promising
  pipeline.
• Identify and understand important and diverse
  types of therapeutics under development for
  Anthrax.
• Develop and design in-licensing and out-licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and scope.
• Modify the therapeutic portfolio by identifying
  discontinued projects and understanding the
  factors that drove them from pipeline.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
6
Anthrax Pipeline Review, H1 2015

• For more details contact Mr. Ritesh Tiwari
  sales_at_rnrmarketresearch.com / 18883915441

RnRMarkertResearch RnRMarketResearch.com, an
online repository of market  research reports,
offers in-depth analysis of over 5000 market
segments. RnR Market Research library has
syndicated reports by leading market research 
publishers across the globe.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441